Denali Therapeutics Inc. is a pioneering biopharmaceutical firm focused on defeating neurodegenerative and lysosomal storage diseases. With a unique approach that involves engineering treatments to cross the blood-brain barrier, Denali is advancing a diverse portfolio. This includes therapies for conditions like Parkinson's disease, amyotrophic lateral sclerosis, and various forms of mucopolysaccharidosis. Collaborating with industry giants like Biogen and Takeda, Denali is at the forefront of developing innovative solutions for complex brain disorders. Founded in 2013, the company is based in South San Francisco, California.
The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names…
Wednesday's additional analyst upgrades and downgrades included CrowdStrike, Ecolab, KKR, Microsoft, Tilray Brands and Twilio.
Monday's top analyst upgrades and downgrades included Broadcom, Costco Wholesale, DraftKings, Exxon Mobil, Foot Locker, Marvell Technology, Nvidia, Payoneer Global, Philip Morris International, Pure Storage, Rivian Automotive, SoFi Technologies, Splunk and Tilray…
Tuesday's top analyst upgrades and downgrades included AT&T, Comcast, First Solar, Fortinet, Jefferies Financial, Next Era Energy Partners, T-Mobile and Walt Disney.
Wednesday’s top analyst upgrades and downgrades included Apple, AMC Entertainment, Facebook, First Solar, Kansas City Southern, Roku and SolarEdge.
Monday's top analyst upgrades and downgrades included Albermarle, Apple, Consolidated Edison, Etsy, GoHealth, Hecla Mining, NortonLifeLock, Pinterest, Switch and T-Mobile.
